Antiviral medication

Molnupiravir    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Molnupiravir: Antiviral medication
Molnupiravir, sold under the brand name Lagevrio among others, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.


You Might Like

Molnupiravir at 63/tablet soon: Hyderabad companies

IndiaTimes - Published

Pharma firms to roll out anti-Covid pill shortly as DCGI approves emergency use

With the Drugs Controller General of India (DCGI) approving the anti-Covid-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately..
IndiaTimes - Published

Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly

IndiaTimes - Published

Optimus Pharma to launch Covid-19 drug Molnupiravir shortly

IndiaTimes - Published

Bio E's Corbevax, SII's Covovax & antiviral drug Molnupiravir get EUA nod

In a significant boost for India’s fight against Covid-19, the Central Drugs Standard Control Organisation (CDSCO) has granted emergency use authorisation for two more Covid-19 vaccines – Corbevax..
IndiaTimes - Published

Covid-19: Govt approves emergency use of Corbevax and Covovax vaccines and anti-viral pill Molnupiravir

The government on Tuesday announced that it has approved emergency use of two more Covid-19 vaccines - Corbevax and Covovax - and Molnupiravir, an anti-viral pill. With the nod from the government for..
IndiaTimes - Published

BREAKING: Corbevax, Covovax, anti-viral drug Molnupiravir approved for emergency use in India

The vaccines that have so far received emergency use authorisation have increased to 8, as of now.
DNA - Published

USFDA nod to clear way for Molnupiravir use in India

IndiaTimes - Published

Govt panel to review EUA application for generic Covid-19 pill

The subject expert committee (SEC) under India's drug regulator is expected to review the EUA applications of drug companies seeking approval for Merck’s antiviral pill, Molnupiravir, on Thursday.
IndiaTimes - Published

Covid: In a first, 5 Indian pharma majors join hands for Molnupiravir clinical trials

IndiaTimes - Published

MSN Labs begins Phase III trials of Molnupiravir on mild to moderate Covid-19 patients

IndiaTimes - Published